P-72 A patient preference study on risk thresholds to switch between daily tablets and biweekly infusions in second-line treatment for advanced hepatocellular carcinomaN. Parikh, A. Girvan,J. Coulter,J. Gable, J. Poon,S. Kim,A. Chatterjee,M. BoeriAnnals of Oncology（2021）引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
